0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Vaccine Administration Market Research Report 2023
Published Date: April 2023
|
Report Code: QYRE-Auto-11Q6037
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Vaccine Administration Market Insights Forecast to 2028
BUY CHAPTERS

Global Vaccine Administration Market Research Report 2023

Code: QYRE-Auto-11Q6037
Report
April 2023
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Global Vaccine Administration Market

The global Vaccine Administration market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Vaccine Administration is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Vaccine Administration is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Vaccine Administration in Paediatrics is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Vaccine Administration include Pfizer, AstraZeneca, Sanofi Aventis, Merck, GlaxoSmithKline, Emergent BioSolutions, Johnson & Johnson, CSL Limited and Serum Institute of India, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Vaccine Administration, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine Administration.
The Vaccine Administration market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Vaccine Administration market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccine Administration companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Scope of Global Vaccine Administration Market Report

Report MetricDetails
Report NameGlobal Vaccine Administration Market
Base Year2022
Forecasted years2023-2029
By Company
  • Pfizer
  • AstraZeneca
  • Sanofi Aventis
  • Merck
  • GlaxoSmithKline
  • Emergent BioSolutions
  • Johnson & Johnson
  • CSL Limited
  • Serum Institute of India
  • Bharat Biotech
  • VBI Vaccines
  • Sinovac Biotech
Segment by Type
  • Viral Diseases
  • Bacterial Diseases
Segment by Application
  • Paediatrics
  • Adults
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
Forecast unitsUSD million in value
Report coverageRevenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Vaccine Administration companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vaccine Administration Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Viral Diseases
1.2.3 Bacterial Diseases
1.3 Market by Application
1.3.1 Global Vaccine Administration Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Paediatrics
1.3.3 Adults
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Vaccine Administration Market Perspective (2018-2029)
2.2 Vaccine Administration Growth Trends by Region
2.2.1 Global Vaccine Administration Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Vaccine Administration Historic Market Size by Region (2018-2023)
2.2.3 Vaccine Administration Forecasted Market Size by Region (2024-2029)
2.3 Vaccine Administration Market Dynamics
2.3.1 Vaccine Administration Industry Trends
2.3.2 Vaccine Administration Market Drivers
2.3.3 Vaccine Administration Market Challenges
2.3.4 Vaccine Administration Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Vaccine Administration Players by Revenue
3.1.1 Global Top Vaccine Administration Players by Revenue (2018-2023)
3.1.2 Global Vaccine Administration Revenue Market Share by Players (2018-2023)
3.2 Global Vaccine Administration Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Vaccine Administration Revenue
3.4 Global Vaccine Administration Market Concentration Ratio
3.4.1 Global Vaccine Administration Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vaccine Administration Revenue in 2022
3.5 Vaccine Administration Key Players Head office and Area Served
3.6 Key Players Vaccine Administration Product Solution and Service
3.7 Date of Enter into Vaccine Administration Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Vaccine Administration Breakdown Data by Type
4.1 Global Vaccine Administration Historic Market Size by Type (2018-2023)
4.2 Global Vaccine Administration Forecasted Market Size by Type (2024-2029)
5 Vaccine Administration Breakdown Data by Application
5.1 Global Vaccine Administration Historic Market Size by Application (2018-2023)
5.2 Global Vaccine Administration Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Vaccine Administration Market Size (2018-2029)
6.2 North America Vaccine Administration Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Vaccine Administration Market Size by Country (2018-2023)
6.4 North America Vaccine Administration Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Vaccine Administration Market Size (2018-2029)
7.2 Europe Vaccine Administration Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Vaccine Administration Market Size by Country (2018-2023)
7.4 Europe Vaccine Administration Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Vaccine Administration Market Size (2018-2029)
8.2 Asia-Pacific Vaccine Administration Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Vaccine Administration Market Size by Region (2018-2023)
8.4 Asia-Pacific Vaccine Administration Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Vaccine Administration Market Size (2018-2029)
9.2 Latin America Vaccine Administration Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Vaccine Administration Market Size by Country (2018-2023)
9.4 Latin America Vaccine Administration Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Vaccine Administration Market Size (2018-2029)
10.2 Middle East & Africa Vaccine Administration Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Vaccine Administration Market Size by Country (2018-2023)
10.4 Middle East & Africa Vaccine Administration Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Vaccine Administration Introduction
11.1.4 Pfizer Revenue in Vaccine Administration Business (2018-2023)
11.1.5 Pfizer Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Vaccine Administration Introduction
11.2.4 AstraZeneca Revenue in Vaccine Administration Business (2018-2023)
11.2.5 AstraZeneca Recent Development
11.3 Sanofi Aventis
11.3.1 Sanofi Aventis Company Detail
11.3.2 Sanofi Aventis Business Overview
11.3.3 Sanofi Aventis Vaccine Administration Introduction
11.3.4 Sanofi Aventis Revenue in Vaccine Administration Business (2018-2023)
11.3.5 Sanofi Aventis Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck Vaccine Administration Introduction
11.4.4 Merck Revenue in Vaccine Administration Business (2018-2023)
11.4.5 Merck Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Vaccine Administration Introduction
11.5.4 GlaxoSmithKline Revenue in Vaccine Administration Business (2018-2023)
11.5.5 GlaxoSmithKline Recent Development
11.6 Emergent BioSolutions
11.6.1 Emergent BioSolutions Company Detail
11.6.2 Emergent BioSolutions Business Overview
11.6.3 Emergent BioSolutions Vaccine Administration Introduction
11.6.4 Emergent BioSolutions Revenue in Vaccine Administration Business (2018-2023)
11.6.5 Emergent BioSolutions Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Detail
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Vaccine Administration Introduction
11.7.4 Johnson & Johnson Revenue in Vaccine Administration Business (2018-2023)
11.7.5 Johnson & Johnson Recent Development
11.8 CSL Limited
11.8.1 CSL Limited Company Detail
11.8.2 CSL Limited Business Overview
11.8.3 CSL Limited Vaccine Administration Introduction
11.8.4 CSL Limited Revenue in Vaccine Administration Business (2018-2023)
11.8.5 CSL Limited Recent Development
11.9 Serum Institute of India
11.9.1 Serum Institute of India Company Detail
11.9.2 Serum Institute of India Business Overview
11.9.3 Serum Institute of India Vaccine Administration Introduction
11.9.4 Serum Institute of India Revenue in Vaccine Administration Business (2018-2023)
11.9.5 Serum Institute of India Recent Development
11.10 Bharat Biotech
11.10.1 Bharat Biotech Company Detail
11.10.2 Bharat Biotech Business Overview
11.10.3 Bharat Biotech Vaccine Administration Introduction
11.10.4 Bharat Biotech Revenue in Vaccine Administration Business (2018-2023)
11.10.5 Bharat Biotech Recent Development
11.11 VBI Vaccines
11.11.1 VBI Vaccines Company Detail
11.11.2 VBI Vaccines Business Overview
11.11.3 VBI Vaccines Vaccine Administration Introduction
11.11.4 VBI Vaccines Revenue in Vaccine Administration Business (2018-2023)
11.11.5 VBI Vaccines Recent Development
11.12 Sinovac Biotech
11.12.1 Sinovac Biotech Company Detail
11.12.2 Sinovac Biotech Business Overview
11.12.3 Sinovac Biotech Vaccine Administration Introduction
11.12.4 Sinovac Biotech Revenue in Vaccine Administration Business (2018-2023)
11.12.5 Sinovac Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Vaccine Administration Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Viral Diseases
    Table 3. Key Players of Bacterial Diseases
    Table 4. Global Vaccine Administration Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 5. Global Vaccine Administration Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 6. Global Vaccine Administration Market Size by Region (2018-2023) & (US$ Million)
    Table 7. Global Vaccine Administration Market Share by Region (2018-2023)
    Table 8. Global Vaccine Administration Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 9. Global Vaccine Administration Market Share by Region (2024-2029)
    Table 10. Vaccine Administration Market Trends
    Table 11. Vaccine Administration Market Drivers
    Table 12. Vaccine Administration Market Challenges
    Table 13. Vaccine Administration Market Restraints
    Table 14. Global Vaccine Administration Revenue by Players (2018-2023) & (US$ Million)
    Table 15. Global Vaccine Administration Market Share by Players (2018-2023)
    Table 16. Global Top Vaccine Administration Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Administration as of 2022)
    Table 17. Ranking of Global Top Vaccine Administration Companies by Revenue (US$ Million) in 2022
    Table 18. Global 5 Largest Players Market Share by Vaccine Administration Revenue (CR5 and HHI) & (2018-2023)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Vaccine Administration Product Solution and Service
    Table 21. Date of Enter into Vaccine Administration Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Vaccine Administration Market Size by Type (2018-2023) & (US$ Million)
    Table 24. Global Vaccine Administration Revenue Market Share by Type (2018-2023)
    Table 25. Global Vaccine Administration Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 26. Global Vaccine Administration Revenue Market Share by Type (2024-2029)
    Table 27. Global Vaccine Administration Market Size by Application (2018-2023) & (US$ Million)
    Table 28. Global Vaccine Administration Revenue Market Share by Application (2018-2023)
    Table 29. Global Vaccine Administration Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 30. Global Vaccine Administration Revenue Market Share by Application (2024-2029)
    Table 31. North America Vaccine Administration Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 32. North America Vaccine Administration Market Size by Country (2018-2023) & (US$ Million)
    Table 33. North America Vaccine Administration Market Size by Country (2024-2029) & (US$ Million)
    Table 34. Europe Vaccine Administration Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 35. Europe Vaccine Administration Market Size by Country (2018-2023) & (US$ Million)
    Table 36. Europe Vaccine Administration Market Size by Country (2024-2029) & (US$ Million)
    Table 37. Asia-Pacific Vaccine Administration Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 38. Asia-Pacific Vaccine Administration Market Size by Region (2018-2023) & (US$ Million)
    Table 39. Asia-Pacific Vaccine Administration Market Size by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Vaccine Administration Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 41. Latin America Vaccine Administration Market Size by Country (2018-2023) & (US$ Million)
    Table 42. Latin America Vaccine Administration Market Size by Country (2024-2029) & (US$ Million)
    Table 43. Middle East & Africa Vaccine Administration Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. Middle East & Africa Vaccine Administration Market Size by Country (2018-2023) & (US$ Million)
    Table 45. Middle East & Africa Vaccine Administration Market Size by Country (2024-2029) & (US$ Million)
    Table 46. Pfizer Company Detail
    Table 47. Pfizer Business Overview
    Table 48. Pfizer Vaccine Administration Product
    Table 49. Pfizer Revenue in Vaccine Administration Business (2018-2023) & (US$ Million)
    Table 50. Pfizer Recent Development
    Table 51. AstraZeneca Company Detail
    Table 52. AstraZeneca Business Overview
    Table 53. AstraZeneca Vaccine Administration Product
    Table 54. AstraZeneca Revenue in Vaccine Administration Business (2018-2023) & (US$ Million)
    Table 55. AstraZeneca Recent Development
    Table 56. Sanofi Aventis Company Detail
    Table 57. Sanofi Aventis Business Overview
    Table 58. Sanofi Aventis Vaccine Administration Product
    Table 59. Sanofi Aventis Revenue in Vaccine Administration Business (2018-2023) & (US$ Million)
    Table 60. Sanofi Aventis Recent Development
    Table 61. Merck Company Detail
    Table 62. Merck Business Overview
    Table 63. Merck Vaccine Administration Product
    Table 64. Merck Revenue in Vaccine Administration Business (2018-2023) & (US$ Million)
    Table 65. Merck Recent Development
    Table 66. GlaxoSmithKline Company Detail
    Table 67. GlaxoSmithKline Business Overview
    Table 68. GlaxoSmithKline Vaccine Administration Product
    Table 69. GlaxoSmithKline Revenue in Vaccine Administration Business (2018-2023) & (US$ Million)
    Table 70. GlaxoSmithKline Recent Development
    Table 71. Emergent BioSolutions Company Detail
    Table 72. Emergent BioSolutions Business Overview
    Table 73. Emergent BioSolutions Vaccine Administration Product
    Table 74. Emergent BioSolutions Revenue in Vaccine Administration Business (2018-2023) & (US$ Million)
    Table 75. Emergent BioSolutions Recent Development
    Table 76. Johnson & Johnson Company Detail
    Table 77. Johnson & Johnson Business Overview
    Table 78. Johnson & Johnson Vaccine Administration Product
    Table 79. Johnson & Johnson Revenue in Vaccine Administration Business (2018-2023) & (US$ Million)
    Table 80. Johnson & Johnson Recent Development
    Table 81. CSL Limited Company Detail
    Table 82. CSL Limited Business Overview
    Table 83. CSL Limited Vaccine Administration Product
    Table 84. CSL Limited Revenue in Vaccine Administration Business (2018-2023) & (US$ Million)
    Table 85. CSL Limited Recent Development
    Table 86. Serum Institute of India Company Detail
    Table 87. Serum Institute of India Business Overview
    Table 88. Serum Institute of India Vaccine Administration Product
    Table 89. Serum Institute of India Revenue in Vaccine Administration Business (2018-2023) & (US$ Million)
    Table 90. Serum Institute of India Recent Development
    Table 91. Bharat Biotech Company Detail
    Table 92. Bharat Biotech Business Overview
    Table 93. Bharat Biotech Vaccine Administration Product
    Table 94. Bharat Biotech Revenue in Vaccine Administration Business (2018-2023) & (US$ Million)
    Table 95. Bharat Biotech Recent Development
    Table 96. VBI Vaccines Company Detail
    Table 97. VBI Vaccines Business Overview
    Table 98. VBI Vaccines Vaccine Administration Product
    Table 99. VBI Vaccines Revenue in Vaccine Administration Business (2018-2023) & (US$ Million)
    Table 100. VBI Vaccines Recent Development
    Table 101. Sinovac Biotech Company Detail
    Table 102. Sinovac Biotech Business Overview
    Table 103. Sinovac Biotech Vaccine Administration Product
    Table 104. Sinovac Biotech Revenue in Vaccine Administration Business (2018-2023) & (US$ Million)
    Table 105. Sinovac Biotech Recent Development
    Table 106. Research Programs/Design for This Report
    Table 107. Key Data Information from Secondary Sources
    Table 108. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Vaccine Administration Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Vaccine Administration Market Share by Type: 2022 VS 2029
    Figure 3. Viral Diseases Features
    Figure 4. Bacterial Diseases Features
    Figure 5. Global Vaccine Administration Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 6. Global Vaccine Administration Market Share by Application: 2022 VS 2029
    Figure 7. Paediatrics Case Studies
    Figure 8. Adults Case Studies
    Figure 9. Vaccine Administration Report Years Considered
    Figure 10. Global Vaccine Administration Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 11. Global Vaccine Administration Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 12. Global Vaccine Administration Market Share by Region: 2022 VS 2029
    Figure 13. Global Vaccine Administration Market Share by Players in 2022
    Figure 14. Global Top Vaccine Administration Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Administration as of 2022)
    Figure 15. The Top 10 and 5 Players Market Share by Vaccine Administration Revenue in 2022
    Figure 16. North America Vaccine Administration Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 17. North America Vaccine Administration Market Share by Country (2018-2029)
    Figure 18. United States Vaccine Administration Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 19. Canada Vaccine Administration Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 20. Europe Vaccine Administration Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. Europe Vaccine Administration Market Share by Country (2018-2029)
    Figure 22. Germany Vaccine Administration Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. France Vaccine Administration Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. U.K. Vaccine Administration Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. Italy Vaccine Administration Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. Russia Vaccine Administration Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. Nordic Countries Vaccine Administration Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Asia-Pacific Vaccine Administration Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Asia-Pacific Vaccine Administration Market Share by Region (2018-2029)
    Figure 30. China Vaccine Administration Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Japan Vaccine Administration Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. South Korea Vaccine Administration Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Southeast Asia Vaccine Administration Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. India Vaccine Administration Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. Australia Vaccine Administration Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Latin America Vaccine Administration Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Latin America Vaccine Administration Market Share by Country (2018-2029)
    Figure 38. Mexico Vaccine Administration Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. Brazil Vaccine Administration Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Middle East & Africa Vaccine Administration Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Middle East & Africa Vaccine Administration Market Share by Country (2018-2029)
    Figure 42. Turkey Vaccine Administration Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Saudi Arabia Vaccine Administration Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Pfizer Revenue Growth Rate in Vaccine Administration Business (2018-2023)
    Figure 45. AstraZeneca Revenue Growth Rate in Vaccine Administration Business (2018-2023)
    Figure 46. Sanofi Aventis Revenue Growth Rate in Vaccine Administration Business (2018-2023)
    Figure 47. Merck Revenue Growth Rate in Vaccine Administration Business (2018-2023)
    Figure 48. GlaxoSmithKline Revenue Growth Rate in Vaccine Administration Business (2018-2023)
    Figure 49. Emergent BioSolutions Revenue Growth Rate in Vaccine Administration Business (2018-2023)
    Figure 50. Johnson & Johnson Revenue Growth Rate in Vaccine Administration Business (2018-2023)
    Figure 51. CSL Limited Revenue Growth Rate in Vaccine Administration Business (2018-2023)
    Figure 52. Serum Institute of India Revenue Growth Rate in Vaccine Administration Business (2018-2023)
    Figure 53. Bharat Biotech Revenue Growth Rate in Vaccine Administration Business (2018-2023)
    Figure 54. VBI Vaccines Revenue Growth Rate in Vaccine Administration Business (2018-2023)
    Figure 55. Sinovac Biotech Revenue Growth Rate in Vaccine Administration Business (2018-2023)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS